share

n-Benzyl-n-Methyl-2-(1-Methyl-4,5,6,7-Tetrahydro-1H-Indazol-4-Yl)Ethanamine CAS NO 878021-42-2


Unit Price:

CAS No.:878021-42-2

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

n-Benzyl-n-Methyl-2-(1-Methyl-4,5,6,7-Tetrahydro-1H-Indazol-4-Yl)Ethanamine CAS NO 878021-42-2 is a high-purity, synthetically derived organic compound featuring a complex molecular structure that combines benzyl, methyl, and tetrahydroindazole moieties. This compound is of significant commercial interest as a key pharmaceutical intermediate and a versatile building block in advanced organic synthesis. It is primarily sought by research institutions and chemical manufacturers engaged in the development of novel active pharmaceutical ingredients (APIs), agrochemicals, and specialty fine chemicals.

Application

  • Pharmaceutical Intermediate: Serves as a critical precursor in the synthesis of novel drug candidates, particularly those targeting neurological and metabolic pathways.
  • Agrochemical Research: Used as a building block for developing new pesticides and herbicides with specific modes of action.
  • Chemical Synthesis: Acts as a versatile scaffold for constructing complex heterocyclic compounds in medicinal and process chemistry.
  • Biochemical Research: Employed in the study of enzyme inhibitors and receptor ligands due to its specific structural features.
  • Material Science: Potential use in the synthesis of advanced organic materials and functional polymers.

Basic Information

Item Details
Product Name n-Benzyl-n-Methyl-2-(1-Methyl-4,5,6,7-Tetrahydro-1H-Indazol-4-Yl)Ethanamine
CAS No. 878021-42-2
Molecular Formula C19H27N3
Molecular Weight 297.44 g/mol
Synonyms N-Benzyl-N-methyl-2-(1-methyl-4,5,6,7-tetrahydro-1H-indazol-4-yl)ethanamine; 1-Methyl-4-[2-(benzylmethylamino)ethyl]-4,5,6,7-tetrahydro-1H-indazole; 878021-42-2; BMTIE; Benzyl-methyl-tetrahydroindazolyl-ethyl-amine
EINECS Contact for details

Quality Control

Our production of n-Benzyl-n-Methyl-2-(1-Methyl-4,5,6,7-Tetrahydro-1H-Indazol-4-Yl)Ethanamine adheres to stringent in-process controls and final release testing to ensure batch-to-batch consistency and high purity. All materials are accompanied by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles. We support compliance with cGMP and ISO 9001 standards for pharmaceutical intermediates, and specifications can be tailored to meet specific project requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after opening to prevent degradation from atmospheric moisture. Keep away from incompatible materials.

Specification

Item Specification
Appearance White to off-white solid
Identification (IR) Conforms to structure
Assay (HPLC) ≥ 98.0%
Related Substances (HPLC) Total impurities ≤ 2.0%
Water Content (KF) ≤ 0.5%
Residue on Ignition ≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.